52244-040 : Edex 40 ug/ml Intracavernous Injection, Powder, Lyophilized, for Solution


NDC52244-040
Labeler: Actient Pharmaceuticals, LLC
Product Type: Human Prescription Drug
Drug Name:  Edex
Dosage Form: Intracavernous Injection, Powder, Lyophilized, for Solution
Application #: NDA020649
Rev. Date: 


NDC Package Codes:

  • 52244-040-02: 2 BLISTER PACK IN 1 CARTON (52244‑040‑02) > 1 CARTRIDGE IN 1 BLISTER PACK > 1 ML IN 1 CARTRIDGE
  • 52244-040-06: 6 BLISTER PACK IN 1 CARTON (52244‑040‑06) > 1 CARTRIDGE IN 1 BLISTER PACK > 1 ML IN 1 CARTRIDGE

Active Ingredients:

  • Alprostadil

Dosage Strength:

  • 40 ug/mL

Pharmaceutical Classes:

  • Genitourinary Arterial Vasodilation [PE]
  • Prostaglandin Analog [EPC]
  • Prostaglandin E1 Agonist [EPC]
  • Prostaglandin Receptor Agonists [MoA]
  • Prostaglandins [CS]
  • Venous Vasodilation [PE]

Related Products:

Based on records with the same trade name.
  • 52244-010 Edex 10 ug/ml Intracavernous Injection, Powder, Lyophilized, for Solution by Actient Pharmaceuticals, LLC
  • 52244-020 Edex 20 ug/ml Intracavernous Injection, Powder, Lyophilized, for Solution by Actient Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 52244-040 QR Code

< Prev: 52244-030Next: 52244-100 >

Related Discussions:

Alprostadil Availability
I'm in Manila Philippines and want to find out where I can buy Alprostadil? I was prescribed Trimix by my doctor in ...
Alprostadil injection alternative - cream/tab/capsule in india
Hi - Does any one know if we have Alprostadil injection alternative - cream/tab/capsules available in india? Cream name ...
edex
availability...




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.